IR News

Jun. 28, 2018Print(PDF/100KB)CSR

Sumitomo Dainippon Pharma Contributes to Northern Osaka Earthquake Relief Efforts in Japan

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura hereinafter called “Sumitomo Dainippon Pharma”) expresses its deepest sympathy for victims of the earthquake with an epicenter in northern Osaka Prefecture on June 18 2018, and our thoughts are with those personally affected by the tragedy.

Sumitomo Dainippon Pharma announced today that the Company will make a donation of JPY 10 million through the Osaka Prefecture to aid relief efforts for victims of the earthquake.